Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             147 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanoma Gerard, Béatrice
1993
29 Supplement 1 p. 711-719
9 p.
artikel
2 Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma Karakousis, C.
1993
29 Supplement 1 p. 1831-1835
5 p.
artikel
3 Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study Bakkevold, K.E.
1993
29 Supplement 1 p. 698-703
6 p.
artikel
4 Adjuvant systemic therapy in breast cancer Mouridsen, H.T.
1993
29 Supplement 1 p. 595-598
4 p.
artikel
5 Advances in systemic treatment of malignant melanoma Aapro, Matti S.
1993
29 Supplement 1 p. 613-617
5 p.
artikel
6 A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium Flemming Geertsen, Poul
1993
29 Supplement 1 p. 347-350
4 p.
artikel
7 A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer Levine, Mark N.
1993
29 Supplement 1 p. 37-43
7 p.
artikel
8 Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy Tilby, M.J.
1993
29 Supplement 1 p. 681-686
6 p.
artikel
9 A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer Jeffry Evans, T.R.
1993
29 Supplement 1 p. 316-319
4 p.
artikel
10 Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer Schor, A.M.
1993
29 Supplement 1 p. 1141-1145
5 p.
artikel
11 A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours Mousseau, M.
1993
29 Supplement 1 p. 753-759
7 p.
artikel
12 A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome Montes, A.
1993
29 Supplement 1 p. 1854-1857
4 p.
artikel
13 Bilateral testicular tumours: Prevalence and clinical implications Bokemeyer, Carsten
1993
29 Supplement 1 p. 874-876
3 p.
artikel
14 Biochemotherapy with dtic and thymosin-α1 (TA1) + interleukin-2 (IL-2) in patients (PTS) with metastatic melanoma (MM) Carpano, S
1993
29 Supplement 1 p. S182-
1 p.
artikel
15 Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens Bartsch, H.
1993
29 Supplement 1 p. 1199-1207
9 p.
artikel
16 Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation Zoetmulder, F.A.N.
1993
29 Supplement 1 p. 957-961
5 p.
artikel
17 CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastases Bombardieri, Emilio
1993
29 Supplement 1 p. 144-146
3 p.
artikel
18 Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer Groen, H.J.M.
1993
29 Supplement 1 p. 1696-1699
4 p.
artikel
19 Central small size breast cancer: How to overcome the problem of nipple and areola involvement Galimberti, V.
1993
29 Supplement 1 p. 1093-1096
4 p.
artikel
20 C-erbB-2/HER-2 protein in human intracranial tumours Torp, Sverre Helge
1993
29 Supplement 1 p. 1604-1606
3 p.
artikel
21 Childhood cancer incidence in the south-east of France Bernard, Jean L.
1993
29 Supplement 1 p. 2284-2291
8 p.
artikel
22 Childhood cancer mortality in the European Community, 1950–1989 Carmen Martos, M.
1993
29 Supplement 1 p. 1783-1789
7 p.
artikel
23 Clinical hyperthermia 1993
29 Supplement 1 p. 1213-
1 p.
artikel
24 Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy Andersson, Anders P.
1993
29 Supplement 1 p. 1712-1714
3 p.
artikel
25 Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer Bergman, Bengt
1993
29 Supplement 1 p. 198-202
5 p.
artikel
26 Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck Volling, Peter
1993
29 Supplement 1 p. 383-389
7 p.
artikel
27 Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2 Yang, James C.
1993
29 Supplement 1 p. 355-359
5 p.
artikel
28 Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents Gondal, Javed A
1993
29 Supplement 1 p. 1536-1542
7 p.
artikel
29 Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney Dewit, L.
1993
29 Supplement 1 p. 2239-2243
5 p.
artikel
30 Continuous intravenous interleukin-2 infusion and subcutaneous interferon-α in metastatic renal cell carcinoma Fosså, Sophie D.
1993
29 Supplement 1 p. 1313-1315
3 p.
artikel
31 Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia Braken, J.B.
1993
29 Supplement 1 p. 515-518
4 p.
artikel
32 Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns Merlo, Adrian
1993
29 Supplement 1 p. 2118-2125
8 p.
artikel
33 [D-Arg1, D-Phe5, D-Trp7,9, Leu11]substance P inhibits the growth of human small cell lung cancer xenografts in vivo Everard, Michele J.
1993
29 Supplement 1 p. 1450-1453
4 p.
artikel
34 21-day schedule oral etoposide in children— a feasibility study Davidson, A.
1993
29 Supplement 1 p. 2223-2225
3 p.
artikel
35 Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts Ruiz van Haperen, Veronique W.T.
1993
29 Supplement 1 p. 2132-2137
6 p.
artikel
36 Detection of the multidrug resistance gene (MDR-1) expression by non-radioactive quantitative polymerase chain reaction Lion, T.
1993
29 Supplement 1 p. S114-
1 p.
artikel
37 Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies Bosset, J.F
1993
29 Supplement 1 p. 1406-1410
5 p.
artikel
38 Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types Schardt, Cordula
1993
29 Supplement 1 p. 2250-2255
6 p.
artikel
39 Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6 Lennette, Evelyne T.
1993
29 Supplement 1 p. 1584-1589
6 p.
artikel
40 DNA pattern and dietary habits in patients with breast cancer Fürst, Carl Johan
1993
29 Supplement 1 p. 1285-1288
4 p.
artikel
41 DNA: The double helix 1993
29 Supplement 1 p. 1213-1215
3 p.
artikel
42 Effect of d,l-verapamil, verapamil enantiomers and verapamil metabolites on the binding of vincristine to α1-acid glycoprotein Woodcock, B.G.
1993
29 Supplement 1 p. 559-561
3 p.
artikel
43 Effect of vinblastine (bolus versus split dose) on SA-1 ascitic tumor cells in mice Serša, G
1993
29 Supplement 1 p. S117-
1 p.
artikel
44 Evaluation of cyfra 21-1 as tumor marker at the diagnosis step in the primary lung cancer Rastel, D.
1993
29 Supplement 1 p. S243-
1 p.
artikel
45 Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group Kylmälä, T.
1993
29 Supplement 1 p. 821-825
5 p.
artikel
46 Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (Vinfosiltine) Fischel, J.L.
1993
29 Supplement 1 p. 1890-1894
5 p.
artikel
47 Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug-resistant phenotype in Chinese hamster ovary cells McClean, Siobhán
1993
29 Supplement 1 p. 2243-2248
6 p.
artikel
48 Experience with prevention of toxicity of taxotere in 1 ECTG centre Schrijvers, D.
1993
29 Supplement 1 p. S209-
1 p.
artikel
49 Expression of epithelial antigens EPM-1 and EXO-1 in normal, transitional, inflammatory and neoplastic colorectal mucosa Klingel, R.
1993
29 Supplement 1 p. 1723-1728
6 p.
artikel
50 Expression of MDR-1 and GSTII gene in human sarcomas Cany, L
1993
29 Supplement 1 p. S113-
1 p.
artikel
51 Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells Mullen, Peter
1993
29 Supplement 1 p. 248-252
5 p.
artikel
52 First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer Bafaloukos, D.
1993
29 Supplement 1 p. 851-853
3 p.
artikel
53 5-Fluorouracil (5FU) plus levdfolinic acid (1-FA) and hydroxyurea (HU) on a weekly schedule in the treatment of metastatic and/or recurrent colorectal adenocarcinoma (CA) Gebbia, V
1993
29 Supplement 1 p. S94-
1 p.
artikel
54 Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer Louvet, Christophe
1993
29 Supplement 1 p. 1835-1838
4 p.
artikel
55 Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients Maiche, A.G
1993
29 Supplement 1 p. 1403-1405
3 p.
artikel
56 Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy Schmidberger, Heinz
1993
29 Supplement 1 p. 1927-1931
5 p.
artikel
57 High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours Kattan, Joseph
1993
29 Supplement 1 p. 1504-1509
6 p.
artikel
58 High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue Schneider, J.
1993
29 Supplement 1 p. 554-558
5 p.
artikel
59 HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer Glover, M.T.
1993
29 Supplement 1 p. 520-524
5 p.
artikel
60 24-Hour plasma etoposide profile after oral and intravenous administration in children Pinkerton, C.R.
1993
29 Supplement 1 p. 1479-1481
3 p.
artikel
61 Human lung cancer: Alterations of parenchymal α1-adrenergic receptors Kondratenko, T.
1993
29 Supplement 1 p. S160-
1 p.
artikel
62 Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours Bartkova, Jirina
1993
29 Supplement 1 p. 881-886
6 p.
artikel
63 Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D Brouillet, J.P.
1993
29 Supplement 1 p. 1248-1251
4 p.
artikel
64 Increased chemosensitivity to doxorubicin of intrinsically multidrug-resistant human colon carcinoma cells by prolonged exposure to verapamil Toffoli, Giuseppe
1993
29 Supplement 1 p. 1776-1778
3 p.
artikel
65 In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment Vitolo, Domenico
1993
29 Supplement 1 p. 371-377
7 p.
artikel
66 Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines Hofbauer, Susanne
1993
29 Supplement 1 p. 241-245
5 p.
artikel
67 Intensive chemotherapy with fluorouracil, epirubicin, cyclophosphamide (FBC) day 1–8 in metastatic breast cancer Bolognesi, A
1993
29 Supplement 1 p. S85-
1 p.
artikel
68 Intermittent continuous intravenous infusion of 5-fluoruoracil; a useful approach in disseminated colorectal cancer? Veenhof, C.H.N.
1993
29 Supplement 1 p. 775-
1 p.
artikel
69 1. Introduction 1993
29 Supplement 1 p. S1-S4
4 p.
artikel
70 In vitro activity of the benzotriazene dioxide SR 4233 against human tumour colony-forming units Hanauske, Axel-R.
1993
29 Supplement 1 p. 423-425
3 p.
artikel
71 In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumours Dietel, Manfred
1993
29 Supplement 1 p. 416-420
5 p.
artikel
72 In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer Lissoni, P.
1993
29 Supplement 1 p. 1127-1132
6 p.
artikel
73 Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases Onier, Nathalie
1993
29 Supplement 1 p. 2003-2009
7 p.
artikel
74 Karyotype in multiple myeloma and plasma cell leukaemia Weh, Hans Josef
1993
29 Supplement 1 p. 1269-1273
5 p.
artikel
75 Lipid-bound sialic acid, prostaglandin e and histamine in head and neck cancer Klapan, Ivica
1993
29 Supplement 1 p. 839-845
7 p.
artikel
76 Local response and long-term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder deKernion, Jean B.
1993
29 Supplement 1 p. 1223-1224
2 p.
artikel
77 MICE: a new active combination for non-small cell lung cancer Arcangeli, Giuseppina
1993
29 Supplement 1 p. 1848-1850
3 p.
artikel
78 Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study Carmo-Pereira, J.
1993
29 Supplement 1 p. 1814-1816
3 p.
artikel
79 Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and wellttolerated regimen for the treatment of advanced breast cancer Wils, J.A.
1993
29 Supplement 1 p. 2106-2108
3 p.
artikel
80 Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours Wegmann, Barbara R
1993
29 Supplement 1 p. 1578-1584
7 p.
artikel
81 5. Monitoring the programme and use of resources 1993
29 Supplement 1 p. S12-S16
5 p.
artikel
82 Neuroblastoma: A multiple biological disease Tonini, Gian Paolo
1993
29 Supplement 1 p. 802-804
3 p.
artikel
83 Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results Lissoni, P
1993
29 Supplement 1 p. 185-189
5 p.
artikel
84 New drugs for breast cancer 1993
29 Supplement 1 p. 1068-
1 p.
artikel
85 [No title] Lennert, K.
1993
29 Supplement 1 p. 913-914
2 p.
artikel
86 Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer Fornander, Tommy
1993
29 Supplement 1 p. 497-500
4 p.
artikel
87 Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy Arpinelli, F.
1993
29 Supplement 1 p. 651-
1 p.
artikel
88 Organisation of screening Tubiana, Maurice
1993
29 Supplement 1 p. 587-588
2 p.
artikel
89 Papers based on oral presentations at the symposium: Applications of recombinant human erythropoietin in cancer patients Florence, Italy, October 29, 1991 Calabresi, Federico
1993
29 Supplement 1 p. S1-
1 p.
artikel
90 Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients de Forni, M.
1993
29 Supplement 1 p. 983-988
6 p.
artikel
91 Phase I–II study of the addition of α-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of α-2a interferon and leucovorin Sinnige, Harm A.M.
1993
29 Supplement 1 p. 1715-1720
6 p.
artikel
92 Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer Planting, A.S.T.
1993
29 Supplement 1 p. 518-519
2 p.
artikel
93 Phase II study of elliptinium acetate salvage treatment of advanced breast cancer Rouëssé, J.
1993
29 Supplement 1 p. 856-859
4 p.
artikel
94 Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC) Chauvergne, J.
1993
29 Supplement 1 p. 350-354
5 p.
artikel
95 Phase II study of weekly 4′-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: An EORTC Gynaecological Cancer Cooperative Group Study van der Burg, M.E.L.
1993
29 Supplement 1 p. 147-148
2 p.
artikel
96 Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer Gridelli, Cesare
1993
29 Supplement 1 p. 1729-1731
3 p.
artikel
97 Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer Peyrat, J.P.
1993
29 Supplement 1 p. 492-497
6 p.
artikel
98 Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells Schwartz-Albiez, R.
1993
29 Supplement 1 p. 1184-1189
6 p.
artikel
99 Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF Kouri, Mauri
1993
29 Supplement 1 p. 1691-1696
6 p.
artikel
100 Potentiation of EO9 anti-tumour activity by hydralazine Bibby, Michael C.
1993
29 Supplement 1 p. 1033-1035
3 p.
artikel
101 Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications Russo, P.
1993
29 Supplement 1 p. 1157-1161
5 p.
artikel
102 Prad-1 gene amplification in head and neck squamous cell carcinoma Klijanienko, J.
1993
29 Supplement 1 p. S144-
1 p.
artikel
103 Pre and post operative values of cyfra 21-1, CEA, SCC, TPA and NSE in primary lung cancer Rastel, D.
1993
29 Supplement 1 p. S247-
1 p.
artikel
104 Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents Vogel, M
1993
29 Supplement 1 p. 2009-2014
6 p.
artikel
105 Prednimustine (sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer Yosef, H.
1993
29 Supplement 1 p. 1100-1105
6 p.
artikel
106 Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma Sweetenham, John W.
1993
29 Supplement 1 p. 190-192
3 p.
artikel
107 Prevention Ojasoo, T.
1993
29 Supplement 1 p. 1071-
1 p.
artikel
108 Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy Hachimi-Idrissi, S.
1993
29 Supplement 1 p. 854-856
3 p.
artikel
109 Primary medical (neo-adjuvant) chemotherapy for operable breast cancer Smith, Ian E.
1993
29 Supplement 1 p. 1796-1799
4 p.
artikel
110 Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer Schmitt, M.
1993
29 Supplement 1 p. S31-
1 p.
artikel
111 Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer Bajetta, Emilio
1993
29 Supplement 1 p. 1658-1663
6 p.
artikel
112 Pulmonary morbidity 10–18 years after irradiation for Hodgkin's disease Hassink, Elly A.M.
1993
29 Supplement 1 p. 343-347
5 p.
artikel
113 Quality of life assessment in a phase 1 study Adams, L
1993
29 Supplement 1 p. S259-
1 p.
artikel
114 Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS) Hollen, Patricia J.
1993
29 Supplement 1 p. S51-S58
8 p.
artikel
115 Quality of life in breast cancer patients: The contribution of data to the care of patients Meyerowitz, B.E.
1993
29 Supplement 1 p. S59-S62
4 p.
artikel
116 Radioimmunoscintigraphy using [111In]antimyosin Fab fragments for the diagnosis and follow-up of rhabdomyosarcoma Hoefnagel, C.A.
1993
29 Supplement 1 p. 2096-2100
5 p.
artikel
117 Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer Mori, Kiyoshi
1993
29 Supplement 1 p. 677-680
4 p.
artikel
118 Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer—A phase I toxicity study and pharmacokinetic analysis Prendiville, J.
1993
29 Supplement 1 p. 1700-1707
8 p.
artikel
119 Regional therapy of melanoma Lejeune, F.J.
1993
29 Supplement 1 p. 606-612
7 p.
artikel
120 Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity Nicholson, R.I.
1993
29 Supplement 1 p. 1018-1023
6 p.
artikel
121 Response of a cancer registry to reports of disease clusters King, Will D.
1993
29 Supplement 1 p. 1414-1418
5 p.
artikel
122 Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb Kroon, Bin B.R.
1993
29 Supplement 1 p. 325-328
4 p.
artikel
123 Sarcomatoid tumours of the breast in Denmark from 1977 to 1987. A clinicopathological and immunohistochemical study of 100 cases Christensen, Lise
1993
29 Supplement 1 p. 1824-1831
8 p.
artikel
124 Sex hormones and anti-hormones 1993
29 Supplement 1 p. 648-
1 p.
artikel
125 Side-effects of GM-CSF treatment in advanced testicular cancer Bokemeyer, Carsten
1993
29 Supplement 1 p. 924-
1 p.
artikel
126 Side-effects of screening Garstin, Ian W.H.
1993
29 Supplement 1 p. 2150-2152
3 p.
artikel
127 Soluble intercellular adhesion molbcule 1 (sICAM-1) in various stages of breast cancer (BC) Shapira, S
1993
29 Supplement 1 p. S243-
1 p.
artikel
128 Steroid action symposium 1993
29 Supplement 1 p. 647-
1 p.
artikel
129 Study of the role of breast self-examination in the reduction of mortality from breast cancer The Russian Federation/World Health Organization Study,
1993
29 Supplement 1 p. 2039-2046
8 p.
artikel
130 Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy Friedl, Andreas
1993
29 Supplement 1 p. 1368-1372
5 p.
artikel
131 Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study Martelli, Gabriele
1993
29 Supplement 1 p. 2080-2082
3 p.
artikel
132 Surveillance following orchidectomy for stage I seminoma of the testis von der Maase, Hans
1993
29 Supplement 1 p. 1931-1934
4 p.
artikel
133 Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines Fischel, J.L.
1993
29 Supplement 1 p. 2269-2273
5 p.
artikel
134 Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours O'Reilly, S.M.
1993
29 Supplement 1 p. 940-942
3 p.
artikel
135 Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group Postmus, Pieter E.
1993
29 Supplement 1 p. 204-207
4 p.
artikel
136 The immunohistochemical detection of CSF-1 (colony stimulating factor-1) in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates Scholl, S.M.
1993
29 Supplement 1 p. S52-
1 p.
artikel
137 The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer Langsteger, Werner
1993
29 Supplement 1 p. 1547-1553
7 p.
artikel
138 The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients Klijn, JGM
1993
29 Supplement 1 p. S59-
1 p.
artikel
139 The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer Cunningham, D.
1993
29 Supplement 1 p. 303-306
4 p.
artikel
140 This article contains errors and has been withdrawn. A corrected version will be published in a later issue of volume 29 of the European journal of cancer 1993
29 Supplement 1 p. 592-595
4 p.
artikel
141 Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule Satta, M.A.
1993
29 Supplement 1 p. 1190-1192
3 p.
artikel
142 Tissue concentrations of prothymosin alpha: A novel proliferation index of primary breast cancer Dominguez, Fernando
1993
29 Supplement 1 p. 893-897
5 p.
artikel
143 Trends in neuroblastoma in Great Britain: Incidence and mortality, 1971–1990 Stiller, C.A.
1993
29 Supplement 1 p. 1008-1012
5 p.
artikel
144 Tumour necrosis factor-α plasma levels after flavone acetic acid administration in man and mouse Chabot, G.G.
1993
29 Supplement 1 p. 729-733
5 p.
artikel
145 Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells Wiseman, Lynda R.
1993
29 Supplement 1 p. 2256-2264
9 p.
artikel
146 Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neck Klijanienko, Jerzy
1993
29 Supplement 1 p. 653-654
2 p.
artikel
147 Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex Willemse, P.H.B.
1993
29 Supplement 1 p. 359-362
4 p.
artikel
                             147 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland